IBDEI0PM ; ; 01-FEB-2022
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 01, 2022
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,11514,2)
 ;;=^5054954
 ;;^UTILITY(U,$J,358.3,11515,0)
 ;;=N25.81^^46^556^36
 ;;^UTILITY(U,$J,358.3,11515,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11515,1,3,0)
 ;;=3^Secondary Hyperparathyroidism of Renal Origin
 ;;^UTILITY(U,$J,358.3,11515,1,4,0)
 ;;=4^N25.81
 ;;^UTILITY(U,$J,358.3,11515,2)
 ;;=^5015617
 ;;^UTILITY(U,$J,358.3,11516,0)
 ;;=T82.858A^^46^556^37
 ;;^UTILITY(U,$J,358.3,11516,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11516,1,3,0)
 ;;=3^Stenosis of Vascular Graft,Init Encntr
 ;;^UTILITY(U,$J,358.3,11516,1,4,0)
 ;;=4^T82.858A
 ;;^UTILITY(U,$J,358.3,11516,2)
 ;;=^5054941
 ;;^UTILITY(U,$J,358.3,11517,0)
 ;;=T82.858D^^46^556^38
 ;;^UTILITY(U,$J,358.3,11517,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11517,1,3,0)
 ;;=3^Stenosis of Vascular Graft,Subs Encntr
 ;;^UTILITY(U,$J,358.3,11517,1,4,0)
 ;;=4^T82.858D
 ;;^UTILITY(U,$J,358.3,11517,2)
 ;;=^5054942
 ;;^UTILITY(U,$J,358.3,11518,0)
 ;;=T82.868A^^46^556^39
 ;;^UTILITY(U,$J,358.3,11518,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11518,1,3,0)
 ;;=3^Thrombosis of Vascular Graft,Init Encntr
 ;;^UTILITY(U,$J,358.3,11518,1,4,0)
 ;;=4^T82.868A
 ;;^UTILITY(U,$J,358.3,11518,2)
 ;;=^5054947
 ;;^UTILITY(U,$J,358.3,11519,0)
 ;;=T82.868D^^46^556^40
 ;;^UTILITY(U,$J,358.3,11519,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11519,1,3,0)
 ;;=3^Thrombosis of Vascular Graft,Subs Encntr
 ;;^UTILITY(U,$J,358.3,11519,1,4,0)
 ;;=4^T82.868D
 ;;^UTILITY(U,$J,358.3,11519,2)
 ;;=^5054948
 ;;^UTILITY(U,$J,358.3,11520,0)
 ;;=N28.1^^46^557^1
 ;;^UTILITY(U,$J,358.3,11520,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11520,1,3,0)
 ;;=3^Cyst of Kidney,Acquired
 ;;^UTILITY(U,$J,358.3,11520,1,4,0)
 ;;=4^N28.1
 ;;^UTILITY(U,$J,358.3,11520,2)
 ;;=^270380
 ;;^UTILITY(U,$J,358.3,11521,0)
 ;;=Q61.9^^46^557^2
 ;;^UTILITY(U,$J,358.3,11521,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11521,1,3,0)
 ;;=3^Cystic Kidney Disease,Unspec
 ;;^UTILITY(U,$J,358.3,11521,1,4,0)
 ;;=4^Q61.9
 ;;^UTILITY(U,$J,358.3,11521,2)
 ;;=^5018800
 ;;^UTILITY(U,$J,358.3,11522,0)
 ;;=Q61.2^^46^557^6
 ;;^UTILITY(U,$J,358.3,11522,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11522,1,3,0)
 ;;=3^Polycystic Kidney,Adult Type
 ;;^UTILITY(U,$J,358.3,11522,1,4,0)
 ;;=4^Q61.2
 ;;^UTILITY(U,$J,358.3,11522,2)
 ;;=^5018796
 ;;^UTILITY(U,$J,358.3,11523,0)
 ;;=Q61.5^^46^557^4
 ;;^UTILITY(U,$J,358.3,11523,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11523,1,3,0)
 ;;=3^Medullary Cystic Kidney
 ;;^UTILITY(U,$J,358.3,11523,1,4,0)
 ;;=4^Q61.5
 ;;^UTILITY(U,$J,358.3,11523,2)
 ;;=^67073
 ;;^UTILITY(U,$J,358.3,11524,0)
 ;;=Z82.71^^46^557^3
 ;;^UTILITY(U,$J,358.3,11524,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11524,1,3,0)
 ;;=3^Family Hx of Polycystic Kidney
 ;;^UTILITY(U,$J,358.3,11524,1,4,0)
 ;;=4^Z82.71
 ;;^UTILITY(U,$J,358.3,11524,2)
 ;;=^321531
 ;;^UTILITY(U,$J,358.3,11525,0)
 ;;=Q61.5^^46^557^5
 ;;^UTILITY(U,$J,358.3,11525,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11525,1,3,0)
 ;;=3^Medullary Sponge Kidney
 ;;^UTILITY(U,$J,358.3,11525,1,4,0)
 ;;=4^Q61.5
 ;;^UTILITY(U,$J,358.3,11525,2)
 ;;=^67073
 ;;^UTILITY(U,$J,358.3,11526,0)
 ;;=Q61.3^^46^557^7
 ;;^UTILITY(U,$J,358.3,11526,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11526,1,3,0)
 ;;=3^Polycystic Kidney,Unspec
 ;;^UTILITY(U,$J,358.3,11526,1,4,0)
 ;;=4^Q61.3
 ;;^UTILITY(U,$J,358.3,11526,2)
 ;;=^5018797
 ;;^UTILITY(U,$J,358.3,11527,0)
 ;;=E11.65^^46^558^11
